The Drug Enforcement Administration will not reschedule marijuana in order to ease restrictions on its use, Acting Administrator Chuck Rosenberg wrote in a letter to petitioners, but it will expand the number of registered manufacturers in an effort to provide medical researchers with a “more varied and robust supply.” The policy change expanding the number of DEA-registered marij... Read More